Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P39060 (
endostatin
)
2,284
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Endostatin was suggested to be an
antiangiogenic agent
with the potential for clinical use in cancer therapy. Unfortunately, up to now no antiangiogenic effect was seen in clinical trials using this substance. The lack of response might be caused by an incomplete understanding of
endostatin
signaling. Endostatin is known to influence the vascular endothelial growth factor (VEGF) signaling pathway. It has been reported to bind to the VEGF receptor KDR directly and to decrease the phosphorylation of endothelial nitric oxide synthase (eNOS) at Ser1177 via the
protein phosphatase 2A
(PP2A). But so far no details of
endostatin
signaling with regard to NO downstream effectors have been revealed. In the present work the authors demonstrate that
endostatin
down-regulates the protein level of soluble guanylate cyclase (sGC) in endothelial cells of newly formed blood vessels in 5 day-old wounds (control: 62.5 +/- 33 vessels/mm2,
endostatin
: 9.2 +/- 3.2 vessels/mm2). This was confirmed in experiments with endothelial tubes of embryoid bodies and endothelial cells derived from embryonic stem cells (eESCs; control: 126 +/- 20,
endostatin
: 58 +/- 10). The decrease of sGC protein levels in response to
endostatin
was abolished after preincubation with the PP2A inhibitor okadaic acid. No alterations of sGC mRNA levels could be found under
endostatin
treatment in eESC. The authors conclude that
endostatin
affects VEGF signaling in endothelial cells by a post-transcriptional PP2A-dependent down-regulation of sGC protein levels.
...
PMID:Endostatin down-regulates soluble guanylate cyclase (sGC) in endothelial cells in vivo: influence of endostatin on vascular endothelial growth factor (VEGF) signaling. 1641 Feb 24
Endostatin, the proteolytic fragment of
collagen XVIII
, is known to be a potent inhibitor of angiogenesis. However, to date, only limited knowledge exists with regard to the effects of
endostatin
on vessel morphology and the underlying signaling pathway. The aim of the present work was therefore to determine the impact of
endostatin
and its collagen XV analogue restin on vessel development during wound healing and embryonic angio- and vasculogenesis. Time lapse experiments and electron microscopy demonstrate similar morphological changes evoked by
endostatin
and the ERK1/2-kinase inhibitor PD98059. Furthermore, we show that ERK1/2 phosphorylation, a crucial signaling event in vascular morphogenesis, is regulated by
endostatin
via the
protein phosphatase 2A
PP2A. These findings provide new insight into a key signaling pathway of vascular remodeling evoked by a matrix-derived factor.
...
PMID:Endostatin influences endothelial morphology via the activated ERK1/2-kinase endothelial morphology and signal transduction. 1665 Aug 78